Skip to main content

XELJANZ

NDC 0069-1029 · Pfizer Laboratories Div Pfizer Inc

Generic nametofacitinib
Dosage formSOLUTION
RouteORAL
Active ingredient(s)TOFACITINIB CITRATE
Strength1 mg/mL
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
Marketing categoryNDA

Packages

0069-1029-02 — 1 BOTTLE in 1 CARTON (0069-1029-02) / 240 mL in 1 BOTTLE (0069-1029-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0054-0821 — tofacitinib, 0069-0501 — tofacitinib, 0069-0502 — tofacitinib, 0069-1001 — tofacitinib, 0069-1002 — tofacitinib, 0574-1811 — Tofacitinib Citrate, 27241-270 — Tofacitinib, 33342-541 — Tofacitinib, 33342-542 — Tofacitinib, 42571-268 — tofacitinib, 42571-377 — tofacitinib, 42799-970 — Tofacitinib, 50228-567 — Tofacitinib citrate, 51991-329 — Tofacitinib Citrate, 51991-963 — Tofacitinib Citrate, 59651-459 — TOFACITINIB, 59651-460 — TOFACITINIB, 59651-685 — TOFACITINIB, 60505-4858 — tofacitinib, 63539-012 — tofacitinib, +27 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.